🇺🇸 FDA
Patent

US 11702657

TRNA/pre-miRNA compositions and methods for treating hepatocellular carcinoma

granted A61PA61P35/00

Quick answer

US patent 11702657 (TRNA/pre-miRNA compositions and methods for treating hepatocellular carcinoma) held by The Regents of the University of California expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P35/00